Haloteco Issues A Voluntary Nationwide Recall of Libipower Plus, a Product Marketed as a Dietary Supplement
Mon, 13 Jul 2009 21:28:00 -0500
Haloteco announced today that it is conducting a nationwide voluntary recall of the company's product sold under the name Libipower Plus. Haloteco is conducting this recall after being informed by the representative of the Food and Drug Administration (FDA) that lab analysis of Libipower Plus samples found that the product contained Tadalalafil which is the active ingredient of FDA approved drugs for Erectile Dysfunction (ED).
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420